Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chewing Gum as a Therapeutic Intervention for the Management of Hypersalivation : a Pilot Study L'Utilisation du Chewing-gum Dans la Prise en Charge de l'hypersialorrhée : Une étude Pilote

NCT07158359 is registered in ClinicalTrials.gov with Centre Hospitalier de Cadillac as lead sponsor.

NCT NCT07158359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07158359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chewing Gum as a Therapeutic Intervention for the Management of Hypersalivation : a Pilot Study L'Utilisation du Chewing-gum Dans la Prise en Charge de l'hypersialorrhée : Une étude Pilote
Lead sponsor
Centre Hospitalier de Cadillac
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2026
Enrollment
46 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypersialorrhea (excessive salivation), psychiatric disorders